Iron deficiency is the world\u2019s most common nutritional deficiency, affecting an estimated two billion people worldwide. The Drakesmith Group is collaborating with researchers across the University and internationally to tackle this problem from multiple angles.
Hashem Koohy, Associate Professor of Systems Immunology, has been awarded funding from Wellcome to develop computational strategies to decipher the underlying rules of adaptive T cell immunity.
Oxford scientists build a connected, \u2018multi-organoid\u2019 platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia.
The foundation has awarded one of its first major research grants to Dr Emily Neil and Professor Anindita Roy from the Childhood Leukaemia Research Group in the MRC Molecular Haematology Unit.
Earlier this year, a group of researchers from the MRC Weatherall Institute of Molecular Medicine attended the Big Bang Fair in Birmingham, showcasing medical research through a series of hands-on activities.
Study led by Psaila Group uncovers previously unknown function of platelets as DNA \u2018vacuum cleaners\u2019 in the blood, with profound implications for cancer diagnosis and prenatal screening.
Claus Nerlov, Professor of Stem Cell Biology, has been awarded funding from Wellcome to map the gene regulatory networks in blood cell production and seek new therapeutic targets.
A research project led jointly by researchers from the University of Oxford, the University of Copenhagen and University of Cambridge shows that large-scale mapping of prehistoric teeth and bones provides new knowledge of present-day infectious diseases. This may, among other things, have an impact on the development of vaccines.
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.
![\"\"](\"https://www.imm.ox.ac.uk/news/mrc-wimm-researchers-receive-full-professor-title/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n